Dr. Harald Hasselmann appointed as new managing director of Eckert & Ziegler BEBIG
As part of the restructuring measures at medical technology company Eckert & Ziegler BEBIG, the Board of Directors has appointed business administration expert Dr. Harald Hasselmann (aged 48) as the new commercial managing director for sales and finances. With effect from October 1, 2015 he will be a member of the management team and head the company together with Dr. Edgar Löffler, a medical physicist, who is responsible for the irradiation equipment manufacturer's technical operations. Abel Luzuriaga, who has been managing director for sales and marketing at Eckert & Ziegler BEBIG since 2012, is leaving the company of his own accord.
Harald Hasselmann, born in Hamburg, has gained extensive experience at various international pharmaceutical companies. He was head of controlling for Europe at Bayer Pharma, managing director at Schering's Hungarian subsidiary and director of the Berlin-based biotech company metaGen. He has held various positions in large and medium-sized healthcare companies and has an excellent track record in sales, controlling and implementing restructuring measures.
The Board of Directors would like to thank Mr. Luzuriaga for his dedication and in particular for his involvement in expanding the market for tumor irradiation equipment.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
